Literature DB >> 6274305

Purification of sphingomyelinase to apparent homogeneity by using hydrophobic chromatography.

C S Jones, P Shankaran, J W Callahan.   

Abstract

Placental sphingomyelinase has been purified to apparent homogeneity by a procedure that makes extensive use of hydrophobic interaction chromatography on sphingosylphosphocholine-CH-, octyl-, hexyl- and Blue-Sepharoses. Enzyme purification is about 10000- 14000-fold over starting extract with excellent yield (usually greater than 28%). Purification of bis-4-methylumbelliferyl phosphate phosphodiesterase activity generally paralleled that of sphingomyelinase during the final stages of the procedure. The enzyme also hydrolysed bis-p-nitrophenyl phosphate, but at a lower rate compared with bis-4-methylumbelliferyl phosphate. A single major protein was observed under non-denaturing conditions. Sphingomyelinase, denatured by reduction and alkylation, is composed of a major polypeptide chain with an apparent molecular weight of 89 100 on sodium dodecyl sulphate/polyacrylamide-gel electrophoresis. Two minor lower-molecular-weight components were consistently obtained at 47 500 and 30 700. These results were also obtained after maleoylation of the reduced and alkylated sample. The enzyme contains a blocked-N-terminal amino acid. An extensive search for contaminating enzymes revealed the presence of minor amounts of acid phosphatase, which were removed from the final enzyme sample. The highly purified enzyme is stable for several weeks when stored with Triton X-100 at 4 degrees C. The pure enzyme aggregates under denaturing and electrophoretic conditions and special care must be taken to ensure that hydrophobic bonding of the protein is decreased as much as possible. The reproducibility and large scale of this procedure should facilitate further study on the structure and kinetic properties of the enzyme.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6274305      PMCID: PMC1162900          DOI: 10.1042/bj1950373

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  21 in total

1.  Purification and characterization of sphingomyelinase from human brain.

Authors:  S Yamaguchi; K Suzuki
Journal:  J Biol Chem       Date:  1977-06-10       Impact factor: 5.157

2.  Solubilization of sphingomyelinase by isotonic extraction of rat brain lysosomes.

Authors:  S Gatt; T Gottesdiner
Journal:  J Neurochem       Date:  1976-02       Impact factor: 5.372

3.  Fibroblast phosphodiesterase deficiency in Niemann-Pick disease.

Authors:  A H Fensom; P F Benson; A W Babarik; A R Grant; L Jacobs
Journal:  Biochem Biophys Res Commun       Date:  1977-02-07       Impact factor: 3.575

4.  Effect of Triton X-100 on the isoelectric focusing profile of fibroblast sphingomyelinase.

Authors:  G T Besley
Journal:  FEBS Lett       Date:  1976-12-15       Impact factor: 4.124

5.  A novel magnesium-independent neutral sphingomyelinase associated with rat central nervous system meylin.

Authors:  S Yamaguchi; K Suzuki
Journal:  J Biol Chem       Date:  1978-06-25       Impact factor: 5.157

6.  Sphingomyelinases in human tissues. IV. Purification of sphingomyelinase from human placenta and effect of Triton X-100.

Authors:  J W Callahan; P Shankaran; M Khalil; J Gerrie
Journal:  Can J Biochem       Date:  1978-09

7.  Sphingomyelinase activity at pH 7.4 in human brain and a comparison to activity at pH 5.0.

Authors:  B G Rao; M W Spence
Journal:  J Lipid Res       Date:  1976-09       Impact factor: 5.922

8.  Measurement of molecular weights by electrophoresis on SDS-acrylamide gel.

Authors:  K Weber; J R Pringle; M Osborn
Journal:  Methods Enzymol       Date:  1972       Impact factor: 1.600

9.  The isolation and characterization of sphingomyelinase from human placental tissue.

Authors:  P G Pentchev; R O Brady; A E Gal; S R Hibbert
Journal:  Biochim Biophys Acta       Date:  1977-08-24

10.  Phosphodiesterases in human tissues. II. Decreased hydrolysis of synthetic substrate by tissues from patients with the Niemann-Pick syndrome.

Authors:  J W Callahan; E L Lassila; M Philippart
Journal:  Biochem Med       Date:  1974-11
View more
  7 in total

1.  A novel mechanism of lysosomal acid sphingomyelinase maturation: requirement for carboxyl-terminal proteolytic processing.

Authors:  Russell W Jenkins; Jolanta Idkowiak-Baldys; Fabio Simbari; Daniel Canals; Patrick Roddy; Clarke D Riner; Christopher J Clarke; Yusuf A Hannun
Journal:  J Biol Chem       Date:  2010-11-22       Impact factor: 5.157

2.  Effect of saposins on acid sphingomyelinase.

Authors:  M Tayama; S Soeda; Y Kishimoto; B M Martin; J W Callahan; M Hiraiwa; J S O'Brien
Journal:  Biochem J       Date:  1993-03-01       Impact factor: 3.857

3.  Studies on the structure of sphingomyelinase. Amino acid composition and heterogeneity on isoelectric focusing.

Authors:  C S Jones; P Shankaran; D J Davidson; A Poulos; J W Callahan
Journal:  Biochem J       Date:  1983-02-01       Impact factor: 3.857

4.  Neutral magnesium-dependent sphingomyelinase from liver plasma membrane: purification and inhibition by ubiquinol.

Authors:  S F Martín; F Navarro; N Forthoffer; P Navas; J M Villalba
Journal:  J Bioenerg Biomembr       Date:  2001-04       Impact factor: 2.945

5.  Deficiency of taurocholate-dependent phospholipase C acting on phosphatidylcholine in Niemann-Pick disease.

Authors:  J R Wherrett; S Huterer
Journal:  Neurochem Res       Date:  1983-01       Impact factor: 3.996

6.  Occurrence of two molecular forms of human acid sphingomyelinase.

Authors:  K Ferlinz; R Hurwitz; G Vielhaber; K Suzuki; K Sandhoff
Journal:  Biochem J       Date:  1994-08-01       Impact factor: 3.857

7.  Characterization of acid sphingomyelinase activity in human cerebrospinal fluid.

Authors:  Christiane Mühle; Hagen B Huttner; Silke Walter; Martin Reichel; Fabio Canneva; Piotr Lewczuk; Erich Gulbins; Johannes Kornhuber
Journal:  PLoS One       Date:  2013-05-02       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.